Alnylam Pharmaceuticals Shares Outstanding 2006-2018 | ALNY

Current and historical number of shares outstanding for Alnylam Pharmaceuticals (ALNY) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $0.090B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.953B 15.11
Gilead Sciences (GILD) United States $100.458B 10.02
Biogen (BIIB) United States $74.492B 15.58
Celgene (CELG) United States $61.777B 12.28
Vertex Pharmaceuticals (VRTX) United States $46.180B 151.02
Illumina (ILMN) United States $44.393B 62.65
Regeneron Pharmaceuticals (REGN) United States $39.282B 23.32
Alexion Pharmaceuticals (ALXN) United States $29.944B 24.92
BioMarin Pharmaceutical (BMRN) United States $18.154B 0.00
Incyte (INCY) United States $14.861B 0.00
Seattle Genetics (SGEN) United States $10.916B 0.00
Sarepta Therapeutics (SRPT) United States $8.957B 0.00
Bluebird Bio (BLUE) United States $8.886B 0.00
BeiGene (BGNE) Cayman Islands $8.774B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.399B 28.09
Exact Sciences (EXAS) United States $7.882B 0.00
Alkermes (ALKS) Ireland $6.910B 0.00
Exelixis (EXEL) United States $6.255B 25.39
Bio-Techne Corp (TECH) United States $5.694B 39.06
Integra LifeSciences Holdings (IART) United States $5.497B 29.50
Galapagos (GLPG) Belgium $5.211B 0.00
Ligand Pharmaceuticals (LGND) United States $4.682B 62.81
Immunomedics (IMMU) United States $4.262B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.198B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.967B 0.00
Array BioPharma (ARRY) United States $3.587B 0.00
China Biologic Products (CBPO) China $3.360B 22.19
Spark Therapeutics (ONCE) United States $3.106B 0.00
Medicines (MDCO) United States $2.967B 0.00
Myriad Genetics (MYGN) United States $2.937B 35.61
Blueprint Medicines (BPMC) United States $2.933B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.918B 0.00
Amicus Therapeutics (FOLD) United States $2.906B 0.00
Ascendis Pharma (ASND) Denmark $2.880B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.834B 0.00
Horizon Pharma Public (HZNP) Ireland $2.817B 17.24
Intercept Pharmaceuticals (ICPT) United States $2.762B 0.00
Emergent Biosolutions (EBS) United States $2.686B 34.34
Halozyme Therapeutics (HALO) United States $2.476B 38.22
Akcea Therapeutics (AKCA) United States $2.437B 0.00
Clovis Oncology (CLVS) United States $2.414B 0.00
REGENXBIO (RGNX) United States $2.398B 55.63
Arena Pharmaceuticals (ARNA) United States $2.167B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.161B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.106B 0.00
Acceleron Pharma (XLRN) United States $2.104B 0.00
Repligen (RGEN) United States $2.087B 66.35
Global Blood Therapeutics (GBT) United States $2.050B 0.00
MyoKardia (MYOK) United States $2.005B 0.00
Puma Biotechnology (PBYI) United States $1.987B 0.00
Insmed (INSM) United States $1.934B 0.00
Genomic Health (GHDX) United States $1.905B 336.56
Cambrex (CBM) United States $1.824B 16.77
Atara Biotherapeutics (ATRA) United States $1.692B 0.00
Aimmune Therapeutics (AIMT) United States $1.689B 0.00
AnaptysBio (ANAB) United States $1.674B 0.00
Editas Medicine (EDIT) United States $1.664B 0.00
IMMURON LTD (IMRN) Australia $1.594B 0.00
Innoviva (INVA) United States $1.513B 11.09
Solid Biosciences (SLDB) United States $1.485B 0.00
G1 THERAPEUTICS (GTHX) United States $1.466B 0.00
Sangamo Therapeutics (SGMO) United States $1.456B 0.00
BIOHAVEN PHARM (BHVN) United States $1.453B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.434B 0.00
Mirati Therapeutics (MRTX) United States $1.422B 0.00
Acorda Therapeutics (ACOR) United States $1.412B 0.00
Audentes Therapeutics (BOLD) United States $1.385B 0.00
Myovant Sciences (MYOV) United Kingdom $1.329B 0.00
Denali Therapeutics (DNLI) United States $1.327B 0.00
UniQure (QURE) Netherlands $1.300B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.286B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.279B 0.00
Intellia Therapeutics (NTLA) United States $1.265B 0.00
Lion Biotechnologies (IOVA) United States $1.242B 0.00
Cellectis (CLLS) France $1.227B 0.00
Athenex (ATNX) United States $1.200B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.192B 0.00
Retrophin (RTRX) United States $1.150B 0.00
NeoGenomics (NEO) United States $1.128B 233.17
Reata Pharmaceuticals (RETA) United States $1.121B 0.00
Intra-Cellular Therapies (ITCI) United States $1.116B 0.00
WAVE Life Sciences (WVE) Singapore $1.087B 0.00
Revance Therapeutics (RVNC) United States $1.081B 0.00
DBV Technologies (DBVT) France $1.067B 0.00
Apellis Pharmaceuticals (APLS) United States $1.048B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.032B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.029B 0.00
Epizyme (EPZM) United States $0.955B 0.00
Dynavax Technologies (DVAX) United States $0.912B 0.00
Coherus BioSciences (CHRS) United States $0.908B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.906B 0.00
CytomX Therapeutics (CTMX) United States $0.906B 0.00
AUTOLUS THERAPT (AUTL) United Kingdom $0.882B 0.00
ANI Pharmaceuticals (ANIP) United States $0.829B 16.98
Amarin (AMRN) Ireland $0.813B 0.00
Heska (HSKA) United States $0.803B 61.53
Sorrento Therapeutics (SRNE) United States $0.797B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.787B 0.00
EIDOS THERAPEUT (EIDX) United States $0.781B 0.00
InflaRx (IFRX) Germany $0.776B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.770B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.768B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.743B 0.00
AC Immune SA (ACIU) Switzerland $0.709B 0.00
Cara Therapeutics (CARA) United States $0.692B 0.00
APTINYX INC (APTX) United States $0.684B 0.00
AVROBIO INC (AVRO) United States $0.673B 0.00
Abeona Therapeutics (ABEO) United States $0.672B 0.00
Viking Therapeutics (VKTX) United States $0.659B 0.00
Kura Oncology (KURA) United States $0.655B 0.00
UROGEN PHARMA (URGN) Israel $0.644B 0.00
UNITY Biotechnology (UBX) $0.640B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.630B 0.00
Fate Therapeutics (FATE) United States $0.615B 0.00
Five Prime Therapeutics (FPRX) United States $0.608B 0.00
Senesco Technologies (ELOX) United States $0.597B 0.00
Arbutus Biopharma (ABUS) Canada $0.596B 0.00
Geron (GERN) United States $0.595B 0.00
BeyondSpring (BYSI) United States $0.583B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Mesoblast (MESO) Australia $0.565B 0.00
ObsEva SA (OBSV) Switzerland $0.561B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.558B 0.00
Merus (MRUS) Netherlands $0.557B 0.00
Aduro Biotech (ADRO) United States $0.547B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.546B 0.00
Tigenix (TIG) Belgium $0.537B 0.00
Anika Therapeutics (ANIK) United States $0.520B 20.62
Arcus Biosciences (RCUS) United States $0.520B 0.00
Novavax (NVAX) United States $0.519B 0.00
Zealand Pharma (ZEAL) Denmark $0.483B 0.00
Cytokineticsorporated (CYTK) United States $0.482B 0.00
Verastem (VSTM) United States $0.472B 0.00
Zymeworks (ZYME) Canada $0.471B 0.00
Stemline Therapeutics (STML) United States $0.469B 0.00
Unum Therapeutics (UMRX) United States $0.449B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.448B 0.00
MAGENTA THERAPT (MGTA) United States $0.447B 0.00
Sinovac Biotech (SVA) China $0.444B 0.00
Evelo Biosciences (EVLO) United States $0.420B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.419B 0.00
Syros Pharmaceuticals (SYRS) United States $0.415B 0.00
Albireo Pharma (ALBO) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.386B 3.94
Inovio Pharmaceuticals (INO) United States $0.376B 0.00
Scholar Rock Holding (SRRK) United States $0.374B 0.00
RA PHARMCTL INC (RARX) United States $0.369B 0.00
MediciNova (MNOV) United States $0.369B 0.00
MiMedx (MDXG) United States $0.358B 15.33
Cellular Biomedicine (CBMG) United States $0.355B 0.00
Mersana Therapeutics (MRSN) United States $0.353B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.340B 0.00
Clearside Biomedical (CLSD) United States $0.340B 0.00
Vericel (VCEL) United States $0.339B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.339B 0.00
Kindred Biosciences (KIN) United States $0.338B 0.00
Vital Therapies (VTL) United States $0.337B 0.00
GTx (GTXI) United States $0.335B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.332B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.330B 0.00
Seres Therapeutics (MCRB) United States $0.326B 0.00
Adverum Biotechnologies (ADVM) United States $0.324B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.310B 0.00
Kala Pharmaceuticals (KALA) United States $0.309B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.299B 0.00
KEZAR LIFE SCI (KZR) United States $0.296B 0.00
Selecta Biosciences (SELB) United States $0.295B 0.00
MEIRAGTX HLDGS (MGTX) United States $0.292B 0.00
Celyad SA (CYAD) Belgium $0.292B 0.00
BioTime (BTX) United States $0.289B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Athersys (ATHX) United States $0.283B 0.00
Synlogic (SYBX) United States $0.282B 0.00
Axovant Sciences (AXON) United Kingdom $0.265B 0.00
Kadmon Holdings (KDMN) United States $0.262B 0.00
OVID THERAPEUTC (OVID) United States $0.253B 0.00
ResTORbio (TORC) United States $0.251B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.248B 0.00
NantKwest (NK) United States $0.244B 0.00
Cue Biopharma (CUE) United States $0.234B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
Strongbridge Biopharma (SBBP) United States $0.232B 0.00
Allena Pharmaceuticals (ALNA) United States $0.232B 0.00
Enzo Biochem (ENZ) United States $0.231B 0.00
ChromaDex (CDXC) United States $0.230B 0.00
MannKind (MNKD) United States $0.230B 0.00
Cohbar (CWBR) United States $0.228B 0.00
Kamada (KMDA) Israel $0.225B 18.07
Celcuity (CELC) United States $0.225B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.224B 0.00
Signal Genetics (MGEN) United States $0.221B 0.00
Agenus (AGEN) United States $0.216B 0.00
Idera Pharmaceuticals (IDRA) United States $0.215B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Monster Digital (INNT) United States $0.208B 0.00
Mustang Bio (MBIO) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.201B 7.77
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.194B 0.00
XOMA (XOMA) United States $0.193B 14.66
Nymox Pharmaceutical (NYMX) Canada $0.193B 0.00
TOCAGEN INC (TOCA) United States $0.187B 0.00
VBI Vaccines (VBIV) United States $0.185B 0.00
Menlo Therapeutics (MNLO) United States $0.183B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.183B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.182B 0.00
Krystal Biotech (KRYS) United States $0.180B 0.00
BioXcel Therapeutics (BTAI) United States $0.179B 0.00
NewLink Genetics (NLNK) United States $0.174B 0.00
BioDelivery Sciences (BDSI) United States $0.169B 0.00
Spero Therapeutics (SPRO) United States $0.168B 0.00
Compugen (CGEN) Israel $0.164B 0.00
Bellerophon Therapeutics (BLPH) United States $0.161B 0.00
Protagonist Therapeutics (PTGX) United States $0.160B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.154B 0.00
Fortress Biotech (FBIO) United States $0.154B 0.00
Intec Pharma (NTEC) Israel $0.150B 0.00
Organovo Holdings (ONVO) United States $0.150B 0.00
XBiotech (XBIT) United States $0.150B 0.00
Catalyst Biosciences (CBIO) United States $0.146B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.143B 0.00
Pluristem Therapeutics (PSTI) Israel $0.142B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.140B 0.00
Anavex Life Sciences (AVXL) United States $0.138B 0.00
Cidara Therapeutics (CDTX) United States $0.134B 0.00
Cerecor (CERC) United States $0.134B 21.30
Motif Bio Plc (MTFB) United States $0.131B 0.00
Cocrystal Pharma (COCP) United States $0.130B 0.00
Pfenex (PFNX) United States $0.123B 0.00
Leap Therapeutics (LPTX) United States $0.122B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.118B 0.00
PSivida (EYPT) United States $0.114B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.114B 0.00
Tapimmune (TPIV) United States $0.108B 0.00
Trevena (TRVN) United States $0.107B 0.00
Aptose Biosciences (APTO) Canada $0.105B 0.00
Aptevo Therapeutics (APVO) United States $0.104B 0.00
Gemphire Therapeutics (GEMP) United States $0.103B 0.00
Proteostasis Therapeutics (PTI) United States $0.100B 0.00
GENPREX INC (GNPX) United States $0.099B 0.00
Eleven Biotherapeutics (SESN) United States $0.096B 0.00
Ophthotech (OPHT) United States $0.096B 0.66
ScPharmaceuticals (SCPH) United States $0.094B 0.00
Sophiris Bio (SPHS) United States $0.092B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.091B 0.00
Asterias Biotherapeutics (AST) United States $0.091B 0.00
Orgenesis (ORGS) United States $0.090B 0.00
Oncolytics Biotech (ONCY) Canada $0.089B 0.00
Alcobra (ARCT) Israel $0.089B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.084B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.082B 0.00
Axsome Therapeutics (AXSM) United States $0.080B 0.00
VIVUS (VVUS) United States $0.078B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Evogene (EVGN) Israel $0.074B 0.00
ENTERA BIO LTD (ENTX) Israel $0.073B 0.00
Celldex Therapeutics (CLDX) United States $0.073B 0.00
Aileron Therapeutics (ALRN) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
Histogenics (HSGX) United States $0.071B 0.00
OncoSec Medical (ONCS) United States $0.070B 0.00
Eyenovia (EYEN) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.070B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Neothetics (EVFM) United States $0.063B 0.00
Curis (CRIS) United States $0.063B 0.00
Vascular Biogenics (VBLT) Israel $0.063B 0.00
Novelion Therapeutics (NVLN) Canada $0.062B 0.00
VolitionRX (VNRX) Singapore $0.060B 0.00
Caladrius Biosciences (CLBS) United States $0.054B 0.00
Celsion (CLSN) United States $0.053B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.048B 0.00
AZURRX BIOPHARM (AZRX) United States $0.047B 0.00
Arsanis (ASNS) United States $0.047B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
Moleculin Biotech (MBRX) United States $0.046B 0.00
Proteon Therapeutics (PRTO) United States $0.042B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
CytRx (CYTR) United States $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
BioPharmX (BPMX) United States $0.040B 0.00
Cellect Biotechnology (APOP) Israel $0.039B 0.00
Chiasma (CHMA) United States $0.037B 0.00
OvaScience (OVAS) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Edge Therapeutics (EDGE) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
Benitec Biopharma (BNTC) Australia $0.031B 0.00
Oncobiologics (ONS) United States $0.028B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
Synthetic Biologics (SYN) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Genetic Technologies (GENE) Australia $0.024B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.024B 0.00
RestorGenex (DFFN) United States $0.024B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
CorMedix Inc (CRMD) United States $0.021B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cel-Sci (CVM) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Cerulean Pharma (DARE) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Flex Pharma (FLKS) United States $0.016B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Fibrocell Science Inc (FCSC) United States $0.014B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.012B 0.00
Galena Biopharma (SLS) United States $0.011B 0.00
Therapix Biosciences (TRPX) Israel $0.011B 5.34
Alliqua BioMedical (ALQA) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Immune Pharmaceuticals (IMNP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.005B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00